Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus

JAMA Dermatology

Volumn 149, Issue 9, 2013, Pages 1077-1081

  Sarin, Kavita Y ^a   Sun, Bryan K ^a   Bangs, Charles D ^a   Cherry, Athena ^a   Swetter, Susan M ^a,b   Kim, Jinah ^a   Khavari, Paul A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 11P; CLINICAL FEATURE; GENE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HRAS GENE; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; HYPERPIGMENTED MACULE; JUVENILE MELANOMA; MALE; MEDICAL HISTORY; MELANOCYSTIC PROLIFERATION; MELANOCYTOSIS; NEVUS; NEVUS SPILUS; PAPULE; PHYSICAL EXAMINATION; POINT MUTATION; PRIORITY JOURNAL;

ADULT; HUMANS; MALE; NEVUS, EPITHELIOID AND SPINDLE CELL; NEVUS, PIGMENTED; POINT MUTATION; PROTO-ONCOGENE PROTEINS P21(RAS); SKIN NEOPLASMS;

EID: 84884678497     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.4745     Document Type: Article

References (15)

1. Da Forno PD, Fletcher A, Pringle JH, Saldanha GS. Understanding spitzoid tumours: new insights from molecular pathology. Br J Dermatol. 2008;158(1):4-14. (Pubitemid 350221887)
2. Mones JM, Ackerman AB. "Atypical" Spitz's nevus, "malignant" Spitz's nevus, and "metastasizing" Spitz's nevus: a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol. 2004;26(4):310-333. (Pubitemid 38989028)
3. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000;157(3):967-972. (Pubitemid 32109388)
4. Fullen DR, Poynter JN, Lowe L, et al. BRAF and NRAS mutations in spitzoid melanocytic lesions. Mod Pathol. 2006;19(10):1324-1332. (Pubitemid 44423079)
5. Wiesner T, Murali R, Fried I, et al. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol. 2012;36(6):818-830.
6. Bastian BC,Wesselmann U, Pinkel D, Leboit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999;113(6):1065-1069. (Pubitemid 30013354)
7. van Dijk MC, Bernsen MR, Ruiter DJ. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. Am J Surg Pathol. 2005;29(9):1145-1151. (Pubitemid 41232985)
8. Harris K, Florell SR, Papenfuss J, et al. Melanoma mimic: a case of multiple pagetoid Spitz nevi. Arch Dermatol. 2012;148(3):370-374.
9. Gantner S, Wiesner T, Cerroni L, et al. Absence of BRAF and HRAS mutations in eruptive Spitz naevi. Br J Dermatol. 2011;164(4):873-877.
10. Boone SL, Busam KJ, Marghoob AA, et al. Two cases of multiple Spitz nevi: correlating clinical, histologic, and fluorescence in situ hybridization findings. Arch Dermatol. 2011;147(2):227-231.
11. Aloi F, Tomasini C, Pippione M. Agminated Spitz nevi occurring within a congenital speckled lentiginous nevus. Am J Dermatopathol. 1995;17(6):594-598. (Pubitemid 26010186)
12. Berk DR, Lane AT. Acquired bilateral agminated Spitz nevi in a child with Langerhans cell histiocytosis. Pediatr Dermatol. 2010;27(3):282-284.
13. Deng X. SeqGene: a comprehensive software solution for mining exome- and transcriptome-sequencing data. BMC Bioinformatics. 2011;12:267. doi:10.1186/1471-2105-12-267.
14. Groesser L, Herschberger E, Sagrera A, et al. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell [published online January 21, 2013]. J Invest Dermatol. doi:10.1038/jid.2013.24.
15. Hafner C, Groesser L. Mosaic RASopathies. Cell Cycle. 2013;12(1):43-50.